Holen Sie sich die Stockscreener-App
1.81
14.62%
-0.31
Handel nachbörslich:
1.90
0.09
+4.97%
Schlusskurs vom Vortag:
$2.12
Offen:
$2.04
24-Stunden-Volumen:
163.72K
Relative Volume:
2.88
Marktkapitalisierung:
$8.54M
Einnahmen:
$98,000
Nettoeinkommen (Verlust:
$-86.59M
KGV:
-0.3321
EPS:
-5.45
Netto-Cashflow:
$-48.49M
1W Leistung:
-33.46%
1M Leistung:
-57.91%
6M Leistung:
-75.20%
1J Leistung:
-86.69%
1-Tages-Spanne:
$1.75
$2.12
1-Wochen-Bereich:
$1.75
$3.10
52-Wochen-Spanne:
$1.75
$19.90
Biora Therapeutics Inc Stock (BIOR) Company Profile
Firmenname
Biora Therapeutics Inc
Sektor
Branche
Telefon
855-293-2639
Adresse
4330 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Vergleichen Sie BIOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BIOR | 1.81 | 8.54M | 98,000 | -86.59M | -48.49M | -5.45 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Biora Therapeutics Inc Aktie (BIOR) Neueste Nachrichten
Biora Therapeutics Reports Q3 2024 Results and Updates - TipRanks
Biora Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Highbridge Capital Management's Strategic Acquisition of Biora T - GuruFocus.com
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire
Biora Therapeutics Advances BioJet Device, Cuts Monthly Expenses 40% Amid Q3 Loss | BIOR Stock News - StockTitan
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Biora Therapeutics Inc (BIOR) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewswire
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SEC Form 424B5 filed by Biora Therapeutics Inc. - Quantisnow
SEC Form 424B3 filed by Biora Therapeutics Inc. - Quantisnow
Biora Therapeutics announces $3 million stock and warrant sale - Investing.com India
Biora Therapeutics advances oral drug delivery tech By Investing.com - Investing.com Nigeria
Biora Therapeutics advances oral drug delivery tech - Investing.com India
Biora Therapeutics Shares Progress on Smaller BioJet™ - GlobeNewswire
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - StockTitan
Progenity Inc stock hits 52-week high of $5.2 amid market fluctuations - Investing.com
Biora Therapeutics Inc’s results are impressive - US Post News
Market Highlights: Biora Therapeutics Inc (BIOR) Ends on a Low Note at 0.55 - The Dwinnex
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting - The Manila Times
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the - GlobeNewswire
Biora Therapeutics enacts reverse stock split, adjusts shares By Investing.com - Investing.com Australia
Biora Therapeutics enacts reverse stock split, adjusts shares - Investing.com India
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium - The Manila Times
Biora Therapeutics Announces Award-Winning Abstract to be - GlobeNewswire
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 - Yahoo Finance
Biora Therapeutics Inc’s Market Journey: Closing Weak at 0.59, Down -9.63 - The Dwinnex
Biora Therapeutics Inc Inc. (BIOR) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Biora Therapeutics secures additional $4 million financing - Investing.com India
Biora Therapeutics secures additional $4 million financing By Investing.com - Investing.com UK
Biora Therapeutics Achieves ISO 13485 Certification - GlobeNewswire
A History of Outperforming Analyst Forecasts and Beating the Odds: Biora Therapeutics Inc (BIOR) - SETE News
Biora Therapeutics Announces Positive Nasdaq Listing Decision - GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Biora Therapeutics secures new financial agreements - Investing.com India
BIOR: Second Quarter Results - Yahoo Finance
Biora Therapeutics, Inc. (NASDAQ:BIOR) Forecasted to Post Q3 2024 Earnings of ($0.42) Per Share - Defense World
BIOR’s Stock Woes: Down -20.37% in 6 Months, Down -20.37% in Just 5 Days - The InvestChronicle
Biora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023) - Yahoo Finance
Biora Therapeutics (NASDAQ:BIOR) Receives “Buy” Rating from HC Wainwright - Defense World
Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call Transcript - Insider Monkey
Biora Therapeutics maintains stock target after strong Q2 results By Investing.com - Investing.com UK
Earnings call: Biora Therapeutics reports progress on BT-600 and BioJet platforms - Investing.com
Finanzdaten der Biora Therapeutics Inc-Aktie (BIOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):